Maryland HB279 establishes a medication review committee to determine the administration of psychotropic medication to incarcerated individuals.

Maryland HB279 creates a medication review committee within the Department of Public Safety and Correctional Services. This committee convenes to decide whether to approve the administration of psychotropic medication to incarcerated individuals under specific circumstances. The committee consists of a chief psychiatrist, another psychiatrist, and a mental health professional who is not a physician. Psychotropic medication cannot be administered to an incarcerated individual who refuses it, except in emergencies or when recommended by a treating practitioner.

Maryland HB279 establishes a medication review committee to determine the administration of psychotropic medication to incarcerated individuals.

Maryland HB279 creates a medication review committee within the Department of Public Safety and Correctional Services. This committee convenes to decide whether to approve the administration of psychotropic medication to incarcerated individuals under specific circumstances. The committee consists of a chief psychiatrist, another psychiatrist, and a mental health professional who is not a physician. Psychotropic medication cannot be administered to an incarcerated individual who refuses it, except in emergencies or when recommended by a treating practitioner.